Literature DB >> 23765740

Oestrogenicity of prenylflavonoids from hops: activation of pro-oestrogens by intestinal bacteria.

Sam Possemiers1, Willy Verstraete.   

Abstract

For many centuries, hops (Humulus lupulus L.) have been used as essential ingredient in beers, providing the typical bitterness and hoppy flavour. However, the last few years the plant has gained increasing attention as a source of prenylflavonoids and in 1999, 8-prenylnaringenin (8-PN) was identified as the most potent phyto-oestrogen known so far. Hop extracts are therefore now marketed to reduce menopausal complaints. However, 8-PN concentrations in hops are very low, and variable efficiency of these extracts was observed. Yet, hops also contain isoxanthohumol (IX) in much higher amounts (IX/8-PN ratio in hop extracts is typically 10-20). This article reviews our recent findings on how the human intestinal microbiota may activate IX. Depending on inter-individual differences in the intestinal transformation potential, this conversion could easily increase the 8-PN exposure 10-fold. The variability in efficacy of hop extracts may therefore be explained by variable intestinal metabolism. Based on this scientific knowledge, an innovative strategy was developed to decrease this variability. First, Eubacterium limosum, capable of rapidly metabolizing all IX into 8-PN, was isolated from the complex intestinal ecosystem. This bacterium was then used to develop a new generation of hop products with increased reliability in effect. This strategy involves the use of the bacterium as probiotic, in which the bacterium is administered in combination with the original hop extract. This leads to efficient intestinal 8-PN production, also in individuals who originally did not harbour the appropriate bacteria. The findings presented in this review can therefore be considered as a typical example that good insight in the specific metabolic potential of complex microbial communities and individual bacterial species may offer important opportunities for the management and modulation of the microbial organization towards a certain metabolic function.
© 2009 Society for Applied Microbiology and Blackwell Publishing Ltd.

Entities:  

Year:  2009        PMID: 23765740     DOI: 10.1111/j.1758-2229.2009.00011.x

Source DB:  PubMed          Journal:  Environ Microbiol Rep        ISSN: 1758-2229            Impact factor:   3.541


  5 in total

Review 1.  The first 1000 cultured species of the human gastrointestinal microbiota.

Authors:  Mirjana Rajilić-Stojanović; Willem M de Vos
Journal:  FEMS Microbiol Rev       Date:  2014-06-27       Impact factor: 16.408

2.  Association of Vitamin B12, Lactate Dehydrogenase, and Regulation of NF-κB in the Mitigation of Sodium Arsenite-Induced ROS Generation in Uterine Tissue by Commercially Available Probiotics.

Authors:  Sandip Chattopadhyay; Shamima Khatun; Moulima Maity; Suryashis Jana; Hasina Perveen; Moumita Dash; Arindam Dey; Lipi Rani Jana; Pikash Pratim Maity
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

3.  Improvements in Metabolic Syndrome by Xanthohumol Derivatives Are Linked to Altered Gut Microbiota and Bile Acid Metabolism.

Authors:  Yang Zhang; Gerd Bobe; Johana S Revel; Richard R Rodrigues; Thomas J Sharpton; Mary L Fantacone; Kareem Raslan; Cristobal L Miranda; Malcolm B Lowry; Paul R Blakemore; Andrey Morgun; Natalia Shulzhenko; Claudia S Maier; Jan F Stevens; Adrian F Gombart
Journal:  Mol Nutr Food Res       Date:  2019-12-15       Impact factor: 5.914

4.  Evaluation of estrogenic potency of a standardized hops extract on mammary gland biology and on MNU-induced mammary tumor growth in rats.

Authors:  Annekathrin M Keiler; Dana Macejova; Birgit M Dietz; Judy L Bolton; Guido F Pauli; Shao-Nong Chen; Richard B van Breemen; Dejan Nikolic; Florian Goerl; Michael H Muders; Oliver Zierau; Günter Vollmer
Journal:  J Steroid Biochem Mol Biol       Date:  2017-09-28       Impact factor: 4.292

5.  Antiviral and Antioxidant Activity of a Hydroalcoholic Extract from Humulus lupulus L.

Authors:  Antonella Di Sotto; Paola Checconi; Ignacio Celestino; Marcello Locatelli; Stefania Carissimi; Marta De Angelis; Valeria Rossi; Dolores Limongi; Chiara Toniolo; Lucia Martinoli; Silvia Di Giacomo; Anna Teresa Palamara; Lucia Nencioni
Journal:  Oxid Med Cell Longev       Date:  2018-07-24       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.